13 December 2017
In a recent study, researchers lead by Professor Kim Midwood at the Kennedy Institute of Rheumatology shed light on how endogenous triggers of inflammation are recognised by immune sensors.
8 November 2017
We would like to congratulate Tariq Khoyratty, who has been appointed as a Celgene Fellow to study the link between neutrophil chromatin organisation in rheumatic patients and their ability to form pathogenic extracellular traps.
12 October 2017
Arthritis Research UK has approved a 5-year renewal of the OA Centre.
Autophagy-dependent generation of free fatty acids is critical for normal neutrophil differentiation
20 September 2017
Recent research from the Simon Group has discovered an unexpected novel role that autophagy plays during the generation of neutrophils.
14 September 2017
Congratulations to our new ARUK Clinical Research Fellows, Dr Malvika Gulati and Miss Jennifer Lane on their successful Fellowship applications.
1 August 2017
Staff at the Kennedy are celebrating receipt of a Bronze Award from Green Impact.
19 July 2017
Fiona Powrie, Director of the Kennedy Institute of Rheumatology is joining Wellcome as a new Governor in Jan 2018. Fiona says she’s thrilled to join Wellcome: "It’s an organisation I’ve admired since I started my research career. Through funding great scientific ideas, Wellcome is committed to promoting health around the world. It will be an honour to help deliver this goal."
16 July 2017
Researchers at the Kennedy Institute of Rheumatology at the University of Oxford mapped dopamine and the consequences of its release to the immunological synapse.
3 July 2017
Dr Anjali Kusumbe has been awarded an MRC Career Development Award to support her research examining how blood vessels support bone growth and repair.
31 May 2017
Christopher Buckley joins the Kennedy Institute as a new Director of Clinical Research from May 2017.
3 April 2017
A new study published today in Nature Medicine could change the lives of millions of people living with inflammatory bowel diseases (IBD) who don’t respond to the current standard of care.
7 December 2016
A new partnership has been formed between the Universities of Oxford and Birmingham to speed up the development of novel treatments for arthritis, supported by a £7 million investment from the Kennedy Trust for Rheumatology Research.